RGEN REPLIGEN CORP
2026Q1 · CUSIP 759916109 · Sector: Healthcare & Biotech
Neutral · No signal
Holders
438
Δ holders QoQ
-36
Breadth percentile
Top 96%
Whale holders
184
Δ whales
-9
Inst. holding value
$7.7B
New positions
66
Closed positions
102
Price momentum (1Q)
-23.0%
Put / Call
5/5
Breadth history (34 quarters)
Past Lit Events & Aftermath 12 lit events
| Period | Percentile | Next-1Q return | Next-2Q return |
|---|---|---|---|
| 2024Q1 | Top 18% | -10.5% | -27.5% |
| 2023Q4 | Top 20% | -17.5% | -26.2% |
| 2022Q3 | Top 2% | -0.5% | -16.6% |
| 2021Q4 | Top 18% | -18.2% | +31.1% |
| 2021Q3 | Top 2% | -31.6% | -44.0% |
| 2020Q4 | Top 10% | -25.2% | +15.5% |
| 2020Q3 | Top 10% | +10.4% | -9.8% |
| 2020Q2 | Top 4% | +38.6% | +45.0% |
Options Sentiment
Put holders
5
QoQ: +1
Call holders
5
QoQ: -5
See methodology →
Fundamentals
PE (TTM)
160.4
EPS (TTM)
$0.91
EPS YoY
—
Revenue (TTM)
$0.8B
Revenue YoY
+17.4%
Quarterly Revenue & EPS (4Y)
Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable
P/E (TTM) over time
P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden
As of 2026-03-31 · SEC filings (XBRL)